25, 2025 /PRNewswire/ -- Akston, the Biotech Built for Pets, announced today the start of a clinical study at Cornell University College of Veterinary Medicine to evaluate its once-weekly GLP-1 weight-management therapy for cats
More and more studies have found that the imbalance of oxidation and antioxidant, and the persistent damage to the brain by oxidative stress play an important role in the occurrence and development of schizophrenia
Participants in a 12-week human clinical study saw significant improvements: Increased GLP-1 by 140% on average Lost 9 lbs in 8 weeks on average and up to 25 lbs in 12 weeks 100% who lost weight did not lose muscle Lost up to 27% in visceral fat 82% took back control of their relationship with food 95% had decreased sugar cravings Benefits Naturally Increases GLP-1 Supports sustainable weight loss and wellness for results you can see and feel
Wegovy (semaglutide) EPAR product information [PDF online]
Liu L, Gao B, Wang J, Yang C, Wu S, Wu Y, et al
It works by stimulating the growth of new blood vessels, promoting collagen production, and reducing inflammation in targeted areas
